# Validation Digital Bio-markers During Sulforaphane Treatment.

> **NCT04805957** · NA · ENROLLING_BY_INVITATION · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 10 (estimated)

## Conditions studied

- Autism
- Autism Spectrum Disorder
- Autistic Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Sulforaphane

## Key facts

- **NCT ID:** NCT04805957
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-07-07
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04805957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04805957, "Validation Digital Bio-markers During Sulforaphane Treatment.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04805957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*